Hemorrhagic fever
MONDO:0600002An infectious disease caused by certain viruses or bacteria that can damage the walls of tiny blood vessels, making them leak, and can hamper the blood's ability to clot and cause severe, life-threatening illness.
Also known as: haemorrhagic fever
54 clinical trials for this condition and its sub-types, 4 tagged with Hemorrhagic fever itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Hemorrhagic fever
-
Viral hemorrhagic fever 10 trials · 51 incl. sub-types
16 sub-types
- Ebola hemorrhagic fever 21 trials
- Dengue hemorrhagic fever 7 trials Sub-types →
- Arenavirus hemorrhagic fever 0 trials · 6 incl. sub-types Sub-types →
- Crimean-Congo hemorrhagic fever 5 trials
- Marburg hemorrhagic fever 4 trials
- Rift valley fever 3 trials
- Hantavirus pulmonary syndrome 2 trials
- Venezuelan equine encephalitis 1 trial
- Hemorrhagic fever-renal syndrome 1 trial
- Bolivian hemorrhagic fever 0 trials
- Brazilian hemorrhagic fever 0 trials
- Chapare hemorrhagic fever 0 trials
- Kyasanur forest disease 0 trials Sub-types →
- Lujo hemorrhagic fever 0 trials
- Omsk hemorrhagic fever 0 trials
- Venezuelan hemorrhagic fever 0 trials
-
Bacterial hemorrhagic fever 0 trials · 3 incl. sub-types
1 sub-type
- Scrub typhus 3 trials
Most studied deeper sub-types
-
Ebola vaccine in a nasal spray? early trial halted
Vaccine Stopped earlyThis early-stage trial tested a nasal spray vaccine against Ebola in 15 healthy adults. The vaccine uses a weakened common cold virus to deliver a piece of the Ebola virus. The study aimed to check safety and immune response, but it was terminated early, so results are limited.
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 11:03 UTC
-
UK volunteers test new ebola vaccine combo in Early-Stage trial
Vaccine Stopped earlyThis early-stage trial tested the safety and immune response of two experimental Ebola vaccines in 38 healthy UK adults. Some volunteers received one vaccine, while others got a prime-boost combination. The vaccines use harmless viruses to train the immune system against Ebola wi…
Phase 1 • Sponsor: University of Oxford • Aim: Vaccine
Last updated Jun 27, 2026 08:05 UTC